ReviewAAPS PharmSciTech2026
Advancement in Sodium Alginate-Based Drug Delivery Systems: Applications and Future Prospects.
Review in AAPS PharmSciTech, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Marine-Derived Polysaccharide Nanofibers for Wound Healing: Mechanistic Rationale, Biofabrication Strategies, and Translational Barriers.Pharmaceuticals (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
For over five decades, sodium alginate (SA) has been widely employed in pharmaceutical formulations due to its environmentally friendly, biodegradable, and biocompatible nature. Primarily sourced from brown seaweed, this natural polymer plays a crucial role in enhancing drug delivery control. It serves as a versatile excipient in numerous dosage forms such as capsules, tablets, liposomes, and microspheres. SA ionotropic gelation with calcium ions allows drug and enzyme encapsulation for controlled release. Structurally, SA consists of α-L-guluronic acid and β-D-mannuronic acid monomers linked via glycosidic bonds, enabling the formation of strong, porous hydrogels capable of carrying bioactive substances. These hydrogels have been extensively utilized in ocular and oral drug delivery systems for prolonged therapeutic effect. This review highlights the structural and physicochemical characteristics of SA, its pharmaceutical and biomedical applications, food industry relevance, and recent innovations, while also discussing its potential as a multifunctional material for future drug delivery systems.
Indexed as
Identifiers
42087019What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.